Chris Walker

Chris Walker is an accomplished professional in the field of clinical development, currently serving as Executive Director at Synnovation Therapeutics since May 2024. Prior experience includes roles as Vice President and Clinical Development Scientist at Immuneering Corporation from July 2021 to January 2024, and various positions at Incyte from March 2012 to July 2021, including Director and Associate Director of Clinical Development. Additional experience encompasses management of clinical research at PharmaNet Development Group, Inc. and study delivery operations at AstraZeneca. Chris Walker earned a Bachelor of Science degree in Biology from Syracuse University, graduating in 1993.